๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Long-term survival in a phase III randomised study of topotecan (T) vs paclitaxel (P) in advanced epithelial ovarian carcinoma

โœ Scribed by Ross, G.; Lane, S.; Dane, G.


Book ID
123465293
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
162 KB
Volume
37
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Paclitaxel, cisplatin, and epirubicin fi
โœ Christos A. Papadimitriou; Lia A. Moulopoulos; Georgios Vlahos; Zannis Voulgaris ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB ๐Ÿ‘ 2 views

## Background: The combination of paclitaxel with cisplatin or carboplatin has become the preferred chemotherapy regimen in the treatment of epithelial ovarian carcinoma. anthracyclines also have activity in this disease. we conducted a phase ii study by using the combination of paclitaxel, cisplat